Standard Biotools | FLDM - Cash And Equivalent

Stock Price
1.37
Daily Change
0.07 5.38%
Monthly
7.03%
Yearly
-29.38%
Q3 Forecast
1.29

Standard Biotools reported $158.62M in Cash and Equivalent for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 556.96M
Cash and Equivalent USD 158.62M
Cost of Sales USD 11.13M
Current Assets USD 506.04M
Current Liabilities USD 98.02M
Debt USD 28.62M
EBIT USD -18.27M
EBITDA USD -14.28M
Employees 534
EPS Earnings Per Share USD -0.05
Equity Capital and Reserves USD 424.54M
Gross Profit on Sales USD 10.63M
Interest Expense on Debt USD 9K
Interest Income 2.46M
Loan Capital USD 299K
Market Capitalization USD 483.9M
Net Income USD -33.46M
Operating Expenses USD 45.46M
Operating Profit USD -23.7M
Ordinary Share Capital USD 381.69M
Pre-Tax Profit USD -18.28M
Sales Revenues USD 21.76M
Selling and Administration Expenses USD 28.1M
Stock USD 24.17M
Trade Creditors USD 7.33M
Trade Debtors USD 14.61M

Cash And Equivalent Change Date
Agilent USD 1.54B 49M Jul/2025
Becton, Dickinson and Co. USD 735M 68M Jun/2025
Bio-Rad Laboratories USD 369.3M 152.1M Jun/2025
Bruker USD 92M 92.2M Jun/2025
Danaher USD 2.96B 964M Jun/2025
Illumina USD 934M 179M Jun/2025
Myriad Genetics USD 91.8M 10.6M Mar/2025
Nikon Corporation JPY 164.74B 1.15B Jun/2025
Revvity USD 991.85M 145.77M Jun/2025
Roche Holding CHF 6.98B 2.15B Dec/2024
Sony JPY 1.6T 1.38T Jun/2025
Standard Biotools USD 158.62M 8.11M Jun/2025
Thermo Fisher Scientific USD 4.58B 442M Jun/2025
Waters USD 367.22M 15.66M Jun/2025